CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Day 2026
    • Funding of the CTGCT
  • Job Openings
  • Products and Services
  • Learning Box
    • Learning Box
    • CTGCT Science Talks
    • Publications
    • CTGCT Days 2025
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

ATMPs

  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
10 October 2025

A Nobel-Worthy Topic: Harnessing Inflammation to Fight Cancer

On October 6th, the very day the 2025 Nobel Prize in Physiology or Medicine was awarded for groundbreaking work in T-cell based cancer immunotherapy, our CTGCT community had the pleasure of hosting a talk ...

Ctgct Science Talks Iva Hafner
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
4 July 2025 Event Date: 15 September 2025 do: 17 September 2025 •

CTGCT Days 2025 – 15th to 17th September, Ljubljana

REGISTER  to join us at CTGCT Days 2025! A 3-day event in Ljubljana, Slovenia, spotlighting breakthroughs in gene & cell therapies (GCT) and their clinical translation.

Cover Image Conference
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Marketaccess
  • CTGCT
  • NIC
  • Gregor Cuzak
20 May 2025 Event Date: 1 May 2025 do: 31 May 2025 •

Posters at Krakovski nasip – Ljubljanica embankment

In May 2025, our Centre for the Technologies of Gene and Cell Therapy CTGCT) is participating in a poster exhibition on Krakovski nasip, as part of the Chemical Institute’s public presentation.

  • Events
  • Clinicians
  • Researchers
  • ATMPs
  • Regulation
  • Research
  • Rodrigo Ortiz
15 April 2025

ADVANCE 5-day Summer School on Cell and Gene Therapies

The next ADVANCE school on ATMP from Faculty of Pharmacy will happen here in Ljubljana. We think is a great FREE opportunity to learn more about ATMPs. Learn more in the official page of ...

Summer school
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • ATMPs
  • Business Model
  • Economics
  • CTGCT
  • UCL
  • Gregor Cuzak
12 February 2025

Introduction to IP and commercialisation – by UCL

The workshop took place on February 3d and was attended by the CTGCT advanced partners only. It provided an in-depth discussion on Intellectual Property (IP) and the process of commercializing research findings. The session ...

  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Economics
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
22 January 2025

Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration

CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA

Erdera
  • Articles
  • Media Releases
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
6 December 2024

CTGCT’s Innovation Report on Gene and Cell Therapy

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

Innovation Report Abstract
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Manufacturing Process
  • Pre Clinical
  • Regulation
  • UCL
  • Rodrigo Ortiz
4 November 2024

Transforming Advanced Therapy Manufacturing: The Braintree Innovation Centre

case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ...

Braintree Mic
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Laboratory
  • Marketaccess
  • Pre Clinical
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
2 October 2024 Event Date: 18 October 2024 −

Program Announcement CTGCT Conference, 18th Oct 2024

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

Posts pagination

1 2 3

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ifeelslovenia Logo 400

Project: 101059842 – CTGCT – HORIZON-WIDERA-
Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.


CTGCT © 2026
Website production: Kreativna tovarna